Lipid Emulsion Infusion and COVID-19 Patients
NCT04957940
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
SMOFlipid
OTHER:
0.9% saline
Sponsor
Assiut University